News
Needham Reiterates Buy on KalVista Pharma, Maintains $35 Price Target
11 Apr 24
News, Price Target, Reiteration, Analyst Ratings
HC Wainwright & Co. Reiterates Buy on KalVista Pharma, Maintains $24 Price Target
12 Mar 24
News, Price Target, Reiteration, Analyst Ratings
Needham Maintains Buy on KalVista Pharma, Maintains $35 Price Target
11 Mar 24
News, Price Target, Analyst Ratings
Recap: KalVista Pharma Q3 Earnings
11 Mar 24
Earnings
KalVista Pharma Q3 EPS $(0.84) Misses $(0.77) Estimate
11 Mar 24
Earnings, News
KalVista Presents Additional Data On Its Phase 3 KONFIDENT Trial For Sebetralstat
26 Feb 24
News
12 Health Care Stocks Moving In Wednesday's After-Market Session
14 Feb 24
Movers
Citigroup To Rally Over 19%? Here Are 10 Top Analyst Forecasts For Wednesday
14 Feb 24
News, Price Target, Small Cap, Pre-Market Outlook, Markets, Analyst Ratings, Trading Ideas
HC Wainwright & Co. Maintains Buy on KalVista Pharma, Raises Price Target to $24
14 Feb 24
News, Price Target, Analyst Ratings
Needham Maintains Buy on KalVista Pharma, Raises Price Target to $35
13 Feb 24
News, Price Target, Analyst Ratings
What's Going With Hereditary Angioedema-Focused KalVista Pharmaceuticals Stock On Tuesday?
13 Feb 24
Biotech, Equities, News, Health Care, Movers, Trading Ideas, General
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
13 Feb 24
Movers
Insiders Buying Monro And 3 Other Stocks
9 Feb 24
Long Ideas, News, Small Cap, Insider Trades, Pre-Market Outlook, Markets, Trading Ideas
$10M Bet On ArriVent BioPharma? Check Out These 4 Stocks Insiders Are Buying
2 Feb 24
Long Ideas, News, Small Cap, Insider Trades, Pre-Market Outlook, Markets, Trading Ideas
Over $1M Bet On This Healthcare Stock? Check Out These 3 Stocks Insiders Are Buying
30 Jan 24
Long Ideas, News, Small Cap, Insider Trades, Pre-Market Outlook, Markets, Trading Ideas
Press releases
KalVista Pharmaceuticals to Present at 23rd Annual Needham Virtual Healthcare Conference
3 Apr 24
Press Releases
KalVista Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2 Apr 24
Press Releases
KalVista Pharmaceuticals Presents Real-World Data on Burden of Treatment and HAE Attack Journey at the 2024 HAEi Regional Conference Americas
18 Mar 24
Press Releases
KalVista Pharmaceuticals Awarded UK Promising Innovative Medicine (PIM) Designation for Sebetralstat
12 Mar 24
Press Releases
KalVista Pharmaceuticals Reports Third Fiscal Quarter Results and Provides Operational Update
11 Mar 24
Press Releases
KalVista Pharmaceuticals to Present HAE Attack Journey Data at 2024 HAEi Regional Conference Americas
8 Mar 24
Press Releases
KalVista Pharmaceuticals Announces Appointment of Benjamin L. Palleiko as Chief Executive Officer
7 Mar 24
Press Releases
KalVista Pharmaceuticals to Participate in the Leerink Partners 2024 Global Biopharma Conference
6 Mar 24
Press Releases
KalVista Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
4 Mar 24
Press Releases
KalVista Pharmaceuticals Presents Data on Unmet Needs in HAE from a Patient Perspective at the 2024 American Academy of Allergy, Asthma & Immunology Annual Meeting
27 Feb 24
Press Releases
KalVista Pharmaceuticals to Present Phase 3 Sebetralstat Data at the 2024 American Academy of Allergy, Asthma & Immunology Annual Meeting
16 Feb 24
Press Releases
KalVista Pharmaceuticals Announces Pricing of a $160.1 Million Public Offering of Common Stock and Pre-Funded Warrants
15 Feb 24
Press Releases
KalVista Pharmaceuticals Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
14 Feb 24
Press Releases
Thinking about trading options or stock in Arm Holdings, Advanced Micro Devices, Shopify, Kalvista Pharmaceuticals, or PG&E?
13 Feb 24
Small Cap, Opinion, Press Releases
KalVista Pharmaceuticals Reports Phase 3 KONFIDENT Trial Meets All Endpoints for Sebetralstat as First Oral On-demand Therapy for Hereditary Angioedema
13 Feb 24
Press Releases
KalVista Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2 Feb 24
Press Releases